IRIS
SVEGLIATI BARONI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.234
EU - Europa 2.777
AS - Asia 1.053
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
SA - Sud America 2
Totale 10.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.201
UA - Ucraina 606
IT - Italia 486
IE - Irlanda 403
SG - Singapore 392
SE - Svezia 375
CN - Cina 373
DE - Germania 272
DK - Danimarca 199
TR - Turchia 142
GB - Regno Unito 133
FI - Finlandia 124
FR - Francia 108
KR - Corea 96
MA - Marocco 42
CI - Costa d'Avorio 39
CA - Canada 32
BE - Belgio 22
IN - India 22
PL - Polonia 17
AT - Austria 6
EU - Europa 6
HK - Hong Kong 6
NL - Olanda 5
RO - Romania 4
TW - Taiwan 4
CH - Svizzera 3
EG - Egitto 3
JP - Giappone 3
RS - Serbia 3
RU - Federazione Russa 3
VN - Vietnam 3
AU - Australia 2
IR - Iran 2
LT - Lituania 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
EC - Ecuador 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
ME - Montenegro 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 10.158
Salva come PNG Salva come JPEG
Città #
Chandler 778
Jacksonville 651
Fairfield 593
Des Moines 459
Dublin 400
Ashburn 396
Boardman 381
Wilmington 283
Woodbridge 268
Houston 243
Seattle 204
Cambridge 190
Singapore 188
New York 181
Centro 172
Lawrence 152
Princeton 152
San Mateo 144
Ann Arbor 142
San Diego 88
Guangzhou 68
Beijing 51
Turin 48
Abidjan 39
Los Angeles 37
London 34
Wuhan 33
Washington 32
Helsinki 28
Ottawa 25
Shanghai 22
Norwalk 21
Pune 20
Redmond 20
Brussels 16
Dallas 16
Ancona 15
Marche 15
Milan 15
Kraków 13
Jiaxing 10
Kilburn 10
Rome 10
Izmir 9
Porto 9
Chiswick 8
Munich 7
Nanjing 7
Antwerp 6
Appignano 6
Civitanova Marche 6
Hong Kong 6
Hounslow 6
Southwark 6
Toronto 6
Yiwu 6
Casoria 5
Falls Church 5
New Bedfont 5
Pescara 5
Torre Annunziata 5
Dearborn 4
Lunano 4
Napoli 4
Prescot 4
Santa Clara 4
Senigallia 4
Shenzhen 4
Vienna 4
Wuxi 4
Acton 3
Belgrade 3
Bologna 3
Falerone 3
Fayetteville 3
Hangzhou 3
Hanover 3
Ho Chi Minh City 3
Jinhua 3
Andover 2
Bristol 2
Cairo 2
Chicago 2
Clifton 2
Edinburgh 2
Frankfurt am Main 2
Genoa 2
Imola 2
Islington 2
Kyiv 2
Nanning 2
Nuremberg 2
Padova 2
Ponsacco 2
Redwood City 2
San Benedetto del Tronto 2
San Giorgio di Piano 2
Shaoxing 2
Slobozia 2
Suzhou 2
Totale 6.881
Salva come PNG Salva come JPEG
Nome #
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 142
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 120
Acetaldehyde-collagen adducts in N-nitrosodimethylamine-induced liver cirrhosis in rats. 106
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 105
Hepatitis E in a region of Italy: An emerging autochthonous infection? 102
Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals 99
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 99
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 95
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 94
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 92
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. 92
From the metabolic syndrome to NAFLD or vice versa? 92
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 91
Predictors of Worse Prognosis in Young and Middle-Aged Adults Hospitalized with COVID-19 Pneumonia: A Multi-Center Italian Study (COVID-UNDER50) 90
Mechanisms for increased risk of diabetes in chronic liver diseases 90
Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of the carboxyl-terminal propeptide of procollagen. 89
Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. 89
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 88
Plasma membrane order parameter in periportal and perivenular hepatocytes isolated from ethanol-treated rats. 88
Immunological risk factors in biliary strictures after liver transplantation 85
Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. 84
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells. 84
Leptin enhances cholangiocarcinoma cell growth. 83
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 82
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 82
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 82
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 82
Fibrogenic effect of oxidative stress on rat hepatic stellate cells. 81
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 81
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 81
Wine: risk factors for liver disease and antifibrotic compounds. 81
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 80
Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area 80
Tocilizumab in COVID-19 interstitial pneumonia 80
Transforming growth factor beta 1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. 79
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 79
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 79
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 79
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. 78
Simultaneous characterization of progenitor cell compartments in adult human liver. 78
Glucagon-like peptide-1receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 78
Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. 77
HIV protein gp120 and chemokines receptor for liver fibrosis. 77
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 77
Liver transplantation in patients with common variable immunodeficiency: a report of two cases 77
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression from NAFLD to NASH 77
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 76
Observer agreement in endoscopic assessment of ulcerative colitis. 75
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 75
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 74
Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease 74
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 74
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights. 73
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with nonalcoholic fatty liver disease 73
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 73
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 72
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 71
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 71
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study 71
Years of life that could be saved from prevention of hepatocellular carcinoma 71
Metabolic disorders across hepatocellular carcinoma in Italy 71
Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients 71
Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. 70
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 70
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease 70
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 70
Regulation of intracellular pH in isolated periportal and perivenular rat hepatocytes. 69
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 69
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 69
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 69
Fibrogenesis in nonalcoholic steatohepatitis. 68
Liver transplantation in neurological Wilson's Disease: is there indication? A case report 68
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. 68
[L-sulpiride versus metoclopramide in functional dyspepsia: a randomized double-blind study] 67
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 67
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. 67
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 65
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. 65
Therapy with direct-acting antiviral agents in transplanted patients with HCV recurrence: a retrospective analysis 65
A 360-degree overview of paediatric NAFLD: Recent insights 64
Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. 64
Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. 64
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 64
Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E) 64
null 64
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 63
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 63
Gut-pancreas-liver axis as a target for treatment of nafld/nash 63
Endogenous opioid peptides and chronic liver disease: from bedside to bench. 62
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. 62
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients. 62
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 62
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 62
Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. 61
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. 61
Effect of cyanidin 3-O-β-glucopyranoside on hepatic stellate cell proliferation and collagen synthesis induced by oxidative stress 61
Lipotoxicity and the gut-liver axis in NASH pathogenesis 61
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 60
Correction to: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (The American Journal of Gastroenterology, (2016), 111, 1, (70-77), 10.1038/ajg.2015.389) 60
BILE ACIDS INDUCE HEPATIC STELLATE CELL PROLIFERATION VIA ACTIVATION OF THE EPIDERMAL GROWTH FACTOR 59
Totale 7.653
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.826
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020552 0 0 0 0 0 7 127 1 138 23 58 198
2020/20212.281 147 219 276 52 258 143 207 163 198 225 258 135
2021/20221.316 81 330 39 31 8 52 84 80 80 95 196 240
2022/20232.538 199 257 164 187 154 645 0 132 541 14 177 68
2023/20241.459 239 37 93 272 216 289 23 55 10 44 17 164
2024/2025955 307 256 122 38 90 142 0 0 0 0 0 0
Totale 10.489